Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-26

FDA Approved: ACETAZOLAMIDE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for acetazolamide filed by Strides Pharma Science Limited, authorizing an update to the generic product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

SUPPL AP for ACETAZOLAMIDE (ACETAZOLAMIDE)